COVID-19 severity and risk of SARS-CoV-2-associated asthma exacerbation by time since booster vaccination: a longitudinal analysis of data from the COVIDENCE UK study
Background COVID-19 booster vaccinations are offered annually to priority groups, but many people have not been vaccinated in over a year. We therefore assessed the association between time since booster vaccination and breakthrough infection characteristics. We also explored whether incident COVID-...
Saved in:
| Main Authors: | Seif O Shaheen, Adrian R Martineau, Paul E Pfeffer, Mohammad Talaei, Giulia Vivaldi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-05-01
|
| Series: | BMJ Open Respiratory Research |
| Online Access: | https://bmjopenrespres.bmj.com/content/12/1/e003158.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of adverse events and comorbidity exacerbation following the COVID-19 booster dose: A national survey among randomly-selected booster recipients.
by: Dvora Frankenthal, et al.
Published: (2025-01-01) -
Evolution of SARS-CoV-2 T cell responses as a function of multiple COVID-19 boosters
by: Ricardo da Silva Antunes, et al.
Published: (2025-07-01) -
Neutralizing antibody responses to SARS-CoV-2 variants after COVID-19 vaccination and boosters
by: Kabita Adhikari, et al.
Published: (2025-06-01) -
Rates of SARS-CoV-2 Breakthrough Infection or Severe COVID-19 and Associated Risk Factors After Primary and Booster Vaccination Against COVID-19 in the Netherlands
by: Jesse M. van den Berg, et al.
Published: (2025-05-01) -
Booster vaccination against the SARS-CoV-2: mechanisms and efficiency
by: S. A. Berns, et al.
Published: (2023-12-01)